Evidence map›Paper›PMID 34203613›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Resveratrol-Loaded Nanoemulsions: In Vitro Activity on Human T24 Bladder Cancer Cells.

Federica Rinaldi, Linda Maurizi, Jacopo Forte, Massimiliano Marazzato, Patrizia Nadia Hanieh, Antonietta Lucia Conte, Maria Grazia Ammendolia, Carlotta Marianecci, Maria Carafa, Catia Longhi

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Nanonutraceuticals Delivery.Nanomaterials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Federica RinaldiDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.
Linda MauriziDipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.
Jacopo ForteDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.ORCID 0000-0002-2405-1983
Massimiliano MarazzatoDipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.
Patrizia Nadia HaniehDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.ORCID 0000-0003-3278-8376
Antonietta Lucia ConteDipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.
Maria Grazia AmmendoliaCentro Nazionale Tecnologie Innovative in Sanità Pubblica, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00162 Rome, Italy.ORCID 0000-0003-4121-3005
Carlotta MarianecciDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.ORCID 0000-0002-2505-1766
Maria CarafaDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.ORCID 0000-0002-3968-3385
Catia LonghiDipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università di Roma, P.le A. Moro 5, 00185 Roma, Italy.ORCID 0000-0001-7290-3813

Funding

Ateneo Sapienza RM11715C458D44ED
6 · The paper itself

Abstract

The chemopreventive potential of Resveratrol (RV) against bladder cancer and its mechanism of action have been widely demonstrated. The physicochemical properties of RV, particularly its high reactivity and low solubility in aqueous phase, have been limiting factors for its bioavailability and in vivo efficacy. In order to overcome these limitations, its inclusion in drug delivery systems needs to be taken into account. In particular, oil-in-water (O/W) nanoemulsions (NEs) have been considered ideal candidates for RV encapsulation. Since surfactant and oil composition can strongly influence NE features and their application field, a ternary phase diagram was constructed and evaluated to select a suitable surfactant/oil/water ratio. The selected sample was deeply characterized in terms of physical chemical features, stability, release capability and cytotoxic activity. Results showed a significant decrease in cell viability after the incubation of bladder T24 cancer cells with RV-loaded NEs, compared to free RV. The selected NE formulation was able to preserve and improve RV cytotoxic activity by a more rapid drug uptake into the cells. O/W NEs represent an effective approach to improve RV bioavailability.

Indexed as

bioactive compoundbladder cellscytotoxicity activityessential oilsnanoemulsionsnanoformulationsresveratrol

Identifiers

PMID34203613
PMCPMC8232283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.